5 Things We’re Talking About in June
Your quick visual roadmap for the hottest medtech topics in [...]
Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.
The VenusP-Valve PROTEUS STUDY, abbreviated from Evaluation of the PerfoRmance [...]
Pfizer Reports | ELREXFIO ™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma
“These compelling overall survival data support the clinical benefit ELREXFIO [...]
Updated Phase 2 CAPTIVATE Study Results
“After more than five years, the CAPTIVATE study findings confirm [...]
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease | Presented at the European Hematology Association (EHA) Annual Congress
“These data confirm the observations from our prior clinical readouts [...]
Innovent Biologics Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer and Other Solid Tumors at the 2024 ESMO Virtual Plenary
Dr. Hui Zhou, Senior Vice President of Innovent, stated: “IBI363, [...]
Sphere Fluidics Awarded Gold Accreditation by Investors in People
Dale Levitzke, CEO of Sphere Fluidics, expressed his pride in [...]
Opthea Limited Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$171.5 million (US$113.2m¹)
“We appreciate the strong support from our shareholders, and from [...]
Roche Sues Sellers Over Counterfeit Diabetes Products Sold on Amazon
The suit alleges that four companies sold expired or nearly [...]
Vyaire Enters into Bankruptcy: Pandemic Success Turns to Financial Struggle
The Chicago, IL-based company is the latest firm that blossomed [...]